<i>ESR1</i> PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies.

J Cancer · 2018 · PMC6096366 · PMID 30123365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

This analysis on 10,300 breast cancer cases and 16,620 controls in PvuII (rs2234693 T>C) polymorphism revealed a borderline significant decreased breast cancer risk for CC and CC/CT carriers (CC vs.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.